therapeutic-depth medical-device-and-diagnostics 
Delveinsight
SEPTEMBER 15, 2021
It is one of the most dynamic segments moving at a rapid pace in terms of research and development activities, diagnostics, and treatment. Significant advancement has been made in cancer diagnostics approaches. Significant advancement has been made in cancer diagnostics approaches. million new cancer cases and 9.5
Delveinsight
SEPTEMBER 15, 2021
The treatment of cancer requires a multidisciplinary approach which includes medications, surgical, and radiation. Oncology is one of the most competitive healthcare domains as several key players at the global level are involved in R&D activities to provide an effective therapeutic option for the people affected with different cancer.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Crucial Data Soutions
JUNE 27, 2022
We’re excited that an industry veteran with Brian’s depth and breadth of experience in eClinical systems has agreed to join the CDS team. Brian Dufresne, B.S., brings over 25 years of sales and leadership experience, the majority of which have been in start-up and emerging growth technology companies.
pharmaphorum
OCTOBER 5, 2021
Leaps forward in both digital tools and widespread collection of medical and health data have provided many opportunities for the healthcare industry to adapt and change. They want personalised care all across the medical care pathway as well. These individuals no longer accept the patient role of past generations.
Drug Discovery World
JULY 11, 2023
Up until this point, there has been limited success in the therapeutic space with AI and ML, as the algorithms can be flawed, the databases (although huge by current standards) are still not comprehensive enough, and our existing computing resources are not sufficient to carry out a proper analysis. However, many questions remain.
XTalks
AUGUST 2, 2023
In this in-depth article, we embark on a captivating journey to uncover the top 30 pharma and biotech companies that have been instrumental in shaping the future of medicine. RELATED: Top 10 Medical Device Companies in 2023: Statistics and Trends 1) Pfizer By: Nadia Stec, M.Sc. billion in 2022, a 23.43 billion, a 42.74
pharmaphorum
JULY 13, 2022
A subgroup of 200 subjects will provide in-depth prospective ‘omics’ data to help identify biomarkers for NSCLC. Ultimately, the goal is to develop novel therapeutic guidelines for clinical practice in lung cancer and support the growth of digital diagnostic tools that will allow treatments to be tailored to individual patients.
Expert insights. Personalized for you.
52 
Let's personalize your content